Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-017871
Filing Date
2020-06-30
Accepted
2020-06-30 06:33:09
Documents
1
Period of Report
2020-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9025
  Complete submission text file 0000899243-20-017871.txt   10403
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Issuer) CIK: 0001805890 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address FUSION PHARMACEUTICALS INC. 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address
Burak Eric (Reporting) CIK: 0001813701 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39344 | Film No.: 201000361